TABLE 1

Demographic and Clinical Patient Characteristics

VariableNo. of patients (% total study population)
Demographic data
 Sex
  Male250 (50)
  Female254 (50)
 Age (y)
  Mean ± SD57 ± 16
  Range20–93
Health-related characteristics
 Body mass index
  Mean ± SD26 ± 5
  Range15–40
 Physical activity24 (5)
 Nicotine intake84 (17)
 Caffeine intake396 (79)
Medication intake*338 (67)
Associated medical conditions
 Diabetes70 (14)
 Hypertension146 (29)
 Dislipidemia116 (23)
 Coronary artery disease†47 (9)
 Heart failure18 (4)
 Valvulopathy24 (5)
 Arrhythmia31 (6)
Cancer-related treatment
 Chemotherapy297 (59)
 Cardiotoxic chemotherapy‡113 (22)
 Radiotherapy to thorax70 (14)
PET/CT study protocol-related indices
 Duration of fast (h)
  Mean ± SD13 ± 5
  Range2–27
 Time from 18F-FDG injection to scan (min)
  Mean ± SD96 ± 16
  Range55–188
 Glucose level (mg/dL)
  Mean ± SD117 ± 35
  Range74–379
 Heart rate (beats/minute)
  Mean ± SD81 ± 10
  Range60–116
 Systolic blood pressure (mm Hg)
  Mean ± SD133 ± 25
  Range80–230
 Diastolic blood pressure (mm Hg)
  Mean ± SD80 ± 11
  Range50–110

  • ↵* Detailed in Table 2.

  • ↵† Including 30 patients (6%) with previous myocardial infarction.

  • ↵‡ Chemotherapy regimens containing anthracyclines: doxorubicin, idarubicin, or epirubicin.